• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Galena Biopharma Inc

+ Add to Watchlist

GALE:US

2.1100 USD 0.0800 3.65%

As of 16:30:00 ET on 09/22/2014.

Snapshot for Galena Biopharma Inc (GALE)

Open: 2.1700 Day's Range: 2.1000 - 2.1800 Volume: 1,070,761
Previous Close: 2.1900 52wk Range: 1.6600 - 7.7700 1-Yr Rtn: +6.03%

Stock Chart for GALE

No chart data available.
  • GALE:US 2.1100
  • 1D
  • 1M
  • 1Y
2.1900
Interactive GALE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GALE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7785
Est. EPS (USD) (12/2014) -0.4110
Est. PEG Ratio -
Market Cap (M USD) 250.63
Shares Outstanding (M) 118.21
30 Day Average Volume 1,889,762
Price/Book (mrq) 8.8047
Price/Sale (ttm) 32.8673
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GALE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GALE

Galena Biopharma, Inc. is a biopharmaceuticals company that develops late-stage oncology drugs. The Company develops therapies that activate cells in the immune system to seek out and eliminate tumor cells without harming healthy tissue.

Mark W SchwartzPresident/CEOBrian L HamiltonExec VP/Chief Medical Officer
Ryan M DunlapVP/CFO/Secretary
More Company Profile & Key Executives for GALE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil